Bavarian Nordic A/SOMXCOP: BAVA

- Transactions in Connection with Share Buy-Back Program

· Issued by Bavarian Nordic A/S

Summary by 6ix AI

Bavarian Nordic A/S, a global vaccine company, bought back more of its own shares from October 12 to October 16, 2026, through Nordea acting on its behalf. Purchases under the program total 824,213 shares at an average price of DKK 218.83, for a transaction value of DKK 180,366,576.

Key details

  • The buy-back program began on September 1, 2026. Under it, Bavarian Nordic will repurchase shares for up to DKK 250 million between September 1, 2026 and October 30, 2026.
  • Daily purchases: 9,000 shares at an average of DKK 239.48 on October 12, 2026; 47,000 at DKK 239.26 on October 13; 31,075 at DKK 236.11 on October 14; 30,925 at DKK 235.92 on October 15; and 49,886 at DKK 238.82 on October 16.
  • Before these purchases, the program total until October 12, 2026 was 656,327 shares at an average price of DKK 213.95, for DKK 140,419,107.
  • After these transactions, Bavarian Nordic holds 4,382,804 of its own shares (treasury shares), equal to 5.53% of its share capital.

What’s still pending

  • The program allows purchases of up to DKK 250 million and runs until October 30, 2026.

6ix AI wrote this summary from the release below and checked it against the release.

Danish English Published: 2026-10-19 10:55:35 CEST Bavarian Nordic A/S - Changes in company's own shares Bavarian Nordic - Transactions in Connection with Share Buy-Back Program

COPENHAGEN, Denmark, October 19, 2026 - Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an amount up to DKK 250 million in the period from September 1, 2026 to October 30, 2026. The program is executed in accordance with Regulation (EU) No. 596/2014 (as amended) of the European Parliament and of the Council on market abuse and Commission Delegated Regulation (EU) 2016/1052, which together constitute the Safe Harbour Regulation.

Since the last announcement of transactions on October 12, 2026, the following transactions have been made by Nordea on behalf of Bavarian Nordic:

Number of shares Average purchase price, DKK Transaction value, DKK
Accumulated until October 12, 2026 656,327 213.95 140,419,107
October 12, 2026 9,000 239.48 2,155,288
October 13, 2026 47,000 239.26 11,245,168
October 14, 2026 31,075 236.11 7,337,202
October 15, 2026 30,925 235.92 7,295,857
October 16, 2026 49,886 238.82 11,913,954
Accumulated under the program 824,213 218.83 180,366,576

The details for each transaction made under the share repurchase program are published on bavarian-nordic.com.

Following these transactions, Bavarian Nordic holds a total of 4,382,804 treasury shares, corresponding to 5.53% of the Company's share capital.

About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com

Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.

Contact investors:
Anders Hjort, Head of Investor Relations, ahjo@bavarian-nordic.com, Tel: +45 44 74 99 58
Graham Morrell, Gilmartin Group, graham@gilmartinir.com, Tel: +1 781 686 9600

Contact media:
Isabel Hagbrink, Head of Media Relations, isha@bavarian-nordic.com, Tel: +45 71 79 67 33

Company Announcement no. 50 / 2026

Attachments

  • Bavarian Nordic - Transactions in Connection with Share Buy-Back Program
  • Appendix with detailed transaction data

2026-50-appendix-en.pdf https://attachment.news.eu.nasdaq.com/ab90c632035d8864a0b35d3a949f62ccd
2026-50-en.pdf https://attachment.news.eu.nasdaq.com/adbf8ff6b830a1eec9f07cea98b30e499
Company News Subscribe European Market Activity Nasdaq Europe
© 2026, Nasdaq, Inc. All Rights Reserved.

Bavarian Nordic A/S on 6ix

Story so far

Earlier from Bavarian Nordic

All Bavarian Nordic news releases